Precision genomics at scale: The strategy, infrastructure, and partnerships behind enterprisewide genomic testing
The promise of precision genomics — care personalized to a patient’s genetic profile — is becoming a reality. According to an HHS analysis, Medicare Part B paid for 18 million genetic tests in 2024, a 160% increase from 2018, and genetic tests now account for 43% of Medicare’s clinical laboratory spending. Still, precision genomics has […] The post Precision genomics at scale: The strategy, infrastructure, and partnerships behind enterprisewide genomic testing appeared first on Becker'...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.